Adds xylazine to the list of Schedule III controlled substances

HB 2749 proposes to add xylazine to the state's list of Schedule III controlled substances, which would subject the drug to stricter regulations similar to those currently applied to prescription painkillers. This legislative change directly impacts law enforcement, healthcare providers, and pharmacies by requiring them to follow specific rules for the storage, dispensing, and monitoring of xylazine. The bill aims to increase oversight of the substance, which is often mixed with other drugs, by formally classifying it under the state's controlled substance laws.